Glucose‐lowering action through targeting islet dysfunction in type 2 diabetes: Focus on dipeptidyl peptidase‐4 inhibition

by Bo Ahrén
Published 2021-07-01

DPP-4 Inhibition and the Path to Clinical Proof

by Bo Ahrén
Published 2019-06-01

Glucagon‐like peptide‐1 receptor agonists for type 2 diabetes: A rational drug development

by Bo Ahrén
Published 2019-03-01

Consequences on islet and incretin hormone responses to dinner by omission of lunch in healthy men

by Ola Lindgren, Bo Ahrén
Published 2020-07-01

Glucose effectiveness: Lessons from studies on insulin‐independent glucose clearance in mice

by Bo Ahrén, Giovanni Pacini
Published 2021-05-01

Estimation of the Relative Contribution of Postprandial Glucose Exposure to Average Total Glucose Exposure in Subjects with Type 2 Diabetes

by Bo Ahrén, James E. Foley
Published 2016-01-01

Differential Development of Glucose Intolerance and Pancreatic Islet Adaptation in Multiple Diet Induced Obesity Models

by Bo Ahrén, Giovanni Pacini, Bilal Omar
Published 2012-09-01

Impact of Incretin Hormone Receptors on Insulin-Independent Glucose Disposal in Model Experiments in Mice

by Tina Ovlund, Giovanni Pacini, Bo Ahrén
Published 2021-06-01

The Insulin Response to Oral Glucose in GIP and GLP-1 Receptor Knockout Mice: Review of the Literature and Stepwise Glucose Dose Response Studies in Female Mice

by Bo Ahrén, Yuichiro Yamada, Yutaka Seino
Published 2021-05-01

Mathematical Model of Glucagon Kinetics for the Assessment of Insulin-Mediated Glucagon Inhibition During an Oral Glucose Tolerance Test

by Micaela Morettini, Laura Burattini, Christian Göbl, Giovanni Pacini, Bo Ahrén, Andrea Tura
Published 2021-03-01

Four-Point Preprandial Self-Monitoring of Blood Glucose for the Assessment of Glycemic Control and Variability in Patients with Type 2 Diabetes Treated with Insulin and Vildaglipti...

by Andrea Tura, Johan Farngren, Anja Schweizer, James E. Foley, Giovanni Pacini, Bo Ahrén
Published 2015-01-01

Hepatic and Extrahepatic Insulin Clearance in Mice with Double Deletion of Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide Receptors

by Micaela Morettini, Agnese Piersanti, Laura Burattini, Giovanni Pacini, Christian Göbl, Bo Ahrén, Andrea Tura
Published 2021-08-01

Four-Year Durability of Initial Combination Therapy with Sitagliptin and Metformin in Patients with Type 2 Diabetes in Clinical Practice; COSMIC Study.

by Eu Jeong Ku, Kyong Yeon Jung, Yoon Ji Kim, Kyoung Min Kim, Jae Hoon Moon, Sung Hee Choi, Young Min Cho, Kyong Soo Park, Hak Chul Jang, Soo Lim, Bo Ahrén
Published 2015-01-01